Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 6

Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil

Authors Divaldo Pereira de Lyra Júnior, Nadir Kheir, Juliana Palma Abriata, Chiara Ermínia da Rocha, Cláudia Benedita dos Santos, et al

Published 15 January 2008 Volume 2007:3(6) Pages 989—998

Divaldo Pereira de Lyra Júnior1, Nadir Kheir2, Juliana Palma Abriata3, Chiara Ermínia da Rocha4, Cláudia Benedita dos Santos5, Irene Rosemir Pelá6

1Faculty of Pharmacy, Federal University of Sergipe, Aracaju, Sergipe, Brazil; 2Pharmacy Program, Qatar University, Doha, Qatar; 3Faculty of Pharmaceutical Sciences, University of Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil; 4Faculty of Pharmacy, Tiradentes University, Aracaju, Sergipe, Brazil; 5Nursing College of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; 6Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

Objective: To evaluate the impact of a Pharmaceutical Care service in the identification and resolution of drug-related problems (DRPs) and in quality of life (QoL) of a group of elderly outpatients with chronic health conditions.

Methods: 30 outpatients (aged 60–75-years old) were followed between August 2003 and July 2004 at a primary health care unit in Ribeirão Preto (SP), Brazil. Patients were scheduled monthly to meet with the researcher, who provided Pharmaceutical Care service (the intervention). Through Pharmaceutical Care, the pharmacist worked with the patient and other care providers to improve outcomes of drug therapy through focused education, care planning, and monitoring. Intervention outcomes were the number of DRPs prevented or resolved, and the impact on QoL. The Short Form-36 health survey was used to measure changes in QoL.

Results: The mean age of patients was 66 ± 5 years, 21 of whom had low literacy. During the study, 92 DRP were identified, 3.0 ± 1.5 problems per patient. By the end of the study, the interventions solved 69% of actual DRP and prevented 78.5% potential DRP. In addition, QoL showed improvement in 22 patients after DRP resolution or prevention.

Conclusion: Despite the limitations in this study that may affect generalizability of the results, this study demonstrates that humanistic and behavioral interventions based on the Pharmaceutical Care model were capable in reducing DRPs, and improve QoL in patients.
Keywords: elderly, pharmaceutical care, quality of life

Download Article [PDF] 

Readers of this article also read:

Lung function decline in COPD

Tantucci C, Modina D

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:95-99

Published Date: 9 February 2012

Vinflunine in the treatment of bladder cancer

Mark Bachner, Maria De Santis

Therapeutics and Clinical Risk Management 2008, 4:1243-1253

Published Date: 5 December 2008

Treatment of severe psoriasis with infliximab

JA Leman, AD Burden

Therapeutics and Clinical Risk Management 2008, 4:1165-1175

Published Date: 5 December 2008

Performance of the OptiMAL® dipstick in the diagnosis of malaria infection in pregnancy

Harry Tagbor, Jane Bruce, Edmund Browne, Brian Greenwood, Daniel Chandramohan

Therapeutics and Clinical Risk Management 2008, 4:631-636

Published Date: 6 June 2008

A critical analysis of barriers to the clinical implementation of pharmacogenomics

Ross A McKinnon, Michael B Ward, Michael J Sorich

Therapeutics and Clinical Risk Management 2007, 3:751-759

Published Date: 15 November 2007

A systematic review of infliximab in the treatment of early rheumatoid arthritis

Sophie Martin Du Pan, Cem Gabay, Axel Finckh

Therapeutics and Clinical Risk Management 2007, 3:905-911

Published Date: 15 November 2007